Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The 830-nm wavelength was most effective at promoting hair growth in rats using low-level laser therapy.

Young women with PCOS without additional risk factors may have normal heart function.

The document concludes that improving the appearance of posttraumatic facial scars is possible with careful treatment and realistic expectations.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Pseudofolliculitis barbae is a chronic skin condition affecting mainly African American and Hispanic individuals, caused by shaving tightly curled hair, and managed by prevention and treatment but not curable.

Tetrathiomolybdate reduces hair growth marker in skin cells by boosting harmful oxygen molecules, but effects can be reversed.

Extracorporeal shock waves significantly improve hair growth in women with female pattern hair loss.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Both steroid treatments effectively regrow hair in severe alopecia areata.

Twice-weekly 5 mg dexamethasone can effectively treat extensive alopecia areata in many patients.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

The combined therapy was effective and safe for children with severe alopecia areata.

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

Method measures minoxidil in tablets accurately and easily.

Twice-weekly 5 mg betamethasone helps hair regrowth in alopecia areata.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

The Nd:YAG laser safely reduces facial hair and slows regrowth, with patient satisfaction.